Biolase, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$4.0Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
5,328clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $343K
2020 $41K
2021 $1.0M
2022 $1.5M
2023 $1.1M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

General Practice (Dentist) $1.4M
Dentist $850K
Endodontics $559K
Periodontics $550K
Pediatric Dentistry $538K
Prosthodontics $13K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Brian Toorani Huntington Beach, CA General Practice (Dentist) $287,763.44
Benjamin Curtis Canton, TX Pediatric Dentistry $214,006.86
Paul Chang Mckinney, TX Periodontics $205,008.93
Stephen John San Carlos, CA Periodontics $190,512.58
Paul Caselle Wilmington, MA General Practice (Dentist) $185,145.30
Bruce Cassis Fayetteville, WV Dentist $183,663.04
Fernando Meza Vienna, VA Endodontics $154,278.58
Charles Maupin Lubbock, TX Dentist $137,912.00
Howard Golan New Hyde Park, NY Dentist $137,203.77
Yigal Zibari Manhattan Beach, CA Endodontics $134,370.52

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.